These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28793370)

  • 1. Prevalence of transactive response DNA-binding protein 43 (TDP-43) proteinopathy in cognitively normal older adults: systematic review and meta-analysis.
    Nascimento C; Di Lorenzo Alho AT; Bazan Conceição Amaral C; Leite REP; Nitrini R; Jacob-Filho W; Pasqualucci CA; Hokkanen SRK; Hunter S; Keage H; Kovacs GG; Grinberg LT; Suemoto CK
    Neuropathol Appl Neurobiol; 2018 Apr; 44(3):286-297. PubMed ID: 28793370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample.
    Nascimento C; Suemoto CK; Rodriguez RD; Alho AT; Leite RP; Farfel JM; Pasqualucci CA; Jacob-Filho W; Grinberg LT
    Brain Pathol; 2016 Mar; 26(2):177-85. PubMed ID: 26260327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use.
    López-Carbonero JI; García-Toledo I; Fernández-Hernández L; Bascuñana P; Gil-Moreno MJ; Matías-Guiu JA; Corrochano S
    Transl Neurodegener; 2024 Jun; 13(1):29. PubMed ID: 38831349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
    Armstrong RA
    Folia Neuropathol; 2016; 54(2):137-48. PubMed ID: 27543771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
    Gao J; Wang L; Yan T; Perry G; Wang X
    Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
    Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
    Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
    Liu YC; Chiang PM; Tsai KJ
    Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New terminology for a common TDP-43 proteinopathy.
    Kurucu H; Spires-Jones T; Smith C
    Lancet Neurol; 2019 Aug; 18(8):714-715. PubMed ID: 31202672
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
    Katsumata Y; Fardo DW; Kukull WA; Nelson PT
    Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans.
    Johnson VE; Stewart W; Trojanowski JQ; Smith DH
    Acta Neuropathol; 2011 Dec; 122(6):715-26. PubMed ID: 22101322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.
    Nelson PT; Gal Z; Wang WX; Niedowicz DM; Artiushin SC; Wycoff S; Wei A; Jicha GA; Fardo DW
    Neurobiol Dis; 2019 May; 125():67-76. PubMed ID: 30682540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy.
    Matsukawa K; Kukharsky MS; Park SK; Park S; Watanabe N; Iwatsubo T; Hashimoto T; Liebman SW; Shelkovnikova TA
    RNA Biol; 2021 Nov; 18(11):1546-1554. PubMed ID: 33427561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Aβ-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC.
    Jamerlan A; An SSA
    Neurobiol Aging; 2020 Nov; 95():161-167. PubMed ID: 32814257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Arezoumandan S; Cai X; Kalkarni P; Davis SA; Wilson K; Ferris CF; Cairns NJ; Gitcho MA
    Neurosci Lett; 2021 Jul; 758():136010. PubMed ID: 34090937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 in aging and Alzheimer's disease - a review.
    Wilson AC; Dugger BN; Dickson DW; Wang DS
    Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.